Matthias Piesche

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Respiratory Syndrome Coronavirus

Replacement Therapy

Transforming Growth Factor

Top Venues

Clinical & translational immunology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kelsey E Huntington, Lindsey Carlsen, Eui-Young So, Matthias Piesche, Olin Liang, Wafik S El-Deiry
Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Ingrid Carvacho, Matthias Piesche
RGD-binding integrins and TGF-β in SARS-CoV-2 infections - novel targets to treat COVID-19 patients? Clinical & translational immunology 10 (3) (2021)